Lyell Immunopharma Inc (LYEL) Insider Trading
In the last 90 days, 20 Lyell Immunopharma Inc (LYEL) insiders reported 14 open-market purchases totaling $349,999,884 and 6 sales totaling $28,757. The most recent open-market purchase was reported on Nov 4, 2026. Source: SEC Form 4 filings.
SEC-reported filing activity is provided for research purposes and is not investment advice.
- 90-day C-suite buyers
- 0
- 90-day purchase value
- $349,999,884
- Corporate buyers
- 14
- Latest transaction
- Nov 10, 2026
Executive filings
Open-market transaction history
Purchase and sale summaries are ordered by the latest reported transaction date.
Common questions
LYEL insider trading FAQ
- Are LYEL insiders buying or selling?
- Over the last 90 days, LYEL insiders were net buyers, reporting $349,999,884 of open-market purchases and $28,757 of sales.
- When was the last LYEL insider purchase?
- The most recent open-market purchase of Lyell Immunopharma Inc stock by an insider was reported on Nov 4, 2026, one of 14 purchases in the last 90 days.
- Where does LYEL insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings that Lyell Immunopharma Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.
Related tickers with recent insider filings
- UTHR insider tradingUnited Therapeutics Corp73 filings
- TWST insider tradingTwist Bioscience Corp31 filings
- NTRA insider tradingNatera Inc28 filings
- ARTV insider tradingArtiva Biotherapeutics Inc20 filings
- RVMD insider tradingRevolution Medicines Inc20 filings
- TEM insider tradingTempus AI Inc20 filings
- CSTL insider tradingCastle Biosciences Inc19 filings
- PACS insider tradingPACS Group Inc.19 filings
